| KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden D Marinelli, M Mazzotta, S Scalera, I Terrenato, F Sperati, L D'Ambrosio, ... Annals of Oncology 31 (12), 1746-1754, 2020 | 164 | 2020 |
| Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants A Massacci, E Sperandio, L D’Ambrosio, M Maffei, F Palombo, ... Journal of Translational Medicine 18, 1-7, 2020 | 20 | 2020 |
| T-cell repertoire diversity: friend or foe for protective antitumor response? N Porciello, O Franzese, L D’Ambrosio, B Palermo, P Nisticò Journal of Experimental & Clinical Cancer Research 41 (1), 356, 2022 | 18 | 2022 |
| ZFP750 affects the cutaneous barrier through regulating lipid metabolism A Butera, M Agostini, M Cassandri, F De Nicola, M Fanciulli, L D’Ambrosio, ... Science Advances 9 (17), eadg5423, 2023 | 7 | 2023 |
| Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patients S Bruschini, M Pallocca, E Sperandio, L D’Ambrosio, F Ascenzi, ... Journal for Immunotherapy of Cancer 10 (5), 2022 | 7 | 2022 |
| CD28/PD1 co-expression: dual impact on CD8+ T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients' survival and ICB response B Palermo, O Franzese, G Frisullo, L D’Ambrosio, M Panetta, G Campo, ... Journal of Experimental & Clinical Cancer Research 42 (1), 287, 2023 | 5 | 2023 |
| Machine learning endometrial cancer risk prediction model: integrating guidelines of European Society for Medical Oncology with the tumor immune framework V Bruno, M Betti, L D’Ambrosio, A Massacci, B Chiofalo, A Pietropolli, ... International Journal of Gynecologic Cancer 33 (11), 2023 | 3 | 2023 |
| Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer F Di Modugno, A Di Carlo, S Spada, B Palermo, L D'Ambrosio, ... Ebiomedicine 101, 2024 | 2 | 2024 |
| hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC P Trono, A Tocci, B Palermo, A Di Carlo, L D'Ambrosio, D D'Andrea, ... Journal for Immunotherapy of Cancer 11 (8), 2023 | 1 | 2023 |
| DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study G Bon, E Krasniqi, M Porru, L D'Ambrosio, S Scalera, M Maugeri-Saccà, ... Neoplasia 45, 100937, 2023 | | 2023 |
| The pattern of expression of hMENA isoforms impacts tumor immune microenvironment of early node-negative non-small cell lung cancer P Nistico, F Di Modugno, S Spada, A Di Carlo, I Sperduti, E Gallo, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | | 2019 |
